摘要
目的:观察“三联疗法”治疗急性脑梗死的临床疗效。方法:治疗组以脉络宁注射液、灯盏花素注射液和精制脑组织液分别静滴治疗100 例急性脑梗死患者,对照组用尿激酶、精制蝮蛇抗栓酶以静脉给药治疗60例急性脑梗死患者。结果:总有效率治疗组与对照组分别为950% 和783% ,治疗组疗效明显优于对照组(P< 001)。2 组患者治疗后全血比粘度、血细胞比容及纤维蛋白原含量均较治疗前明显下降(P均< 001),但治疗后2 组血液流变学各项指标比较无明显差异。结论:“三联疗法”治疗急性脑梗死疗效肯定。
Objective:To observe the clinically curative effects of triple combined therapy (TCT) on acutely cerebral infarctions(ACI).Methods:100 cases with ACI (treatment group) were treated with Mailuoning Injection(脉络宁注射液),Dengzhanhuasu Injection(灯盏花素注射液) and refined brain tissue injection separately infused intravenously but control group ( n =60) was treated with urokinase and refined ahalysantinfarctiasum.Results:In treatment group the total effective rate was 95 0% while it was 78 3% in control group.The curative effects in treatment group were better than those in control group significantly ( P <0 01).After therapy the whole blood comparative viscosity,the comperative volume of blood cells,and the concentrations of fibrinogen were significantly lower than those before therapy (all P <0 01).After therapy in both two groups the rheologic parameters had not obvious abnormalities.Conclusions:The curative effects of TCT on ACI are confirmed and have not harmful reaction to be found.
出处
《中国中西医结合急救杂志》
CAS
1999年第9期406-407,共2页
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
关键词
脑梗死
脉络宁
注射液
灯盏花素
精制脑组织液
acutely cerebral infarction
Mailuoning Injection
Dengzhanhuasu Injection
refined brain tissue injection
urokinase
ahalysantinfarctasum
blood rehology